NPI-001 is Nacuity’s investigational therapy for the treatment of patients with retinitis pigmentosa (RP).
NAC N-acetyl cysteine
NPI-001 is Nacuity’s investigational therapy for the treatment of patients with retinitis pigmentosa (RP).
NAC N-acetyl cysteine